Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 12, 2025
The 2025 ATA guidelines for differentiated thyroid Cancer - Ten years of professional debate and measured progress
Petra Petranović Ovčariček, Frederik Anton Verburg, Bart de Keizer, et al.
Biomedicines
|
September 28, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
Rie von Eyben, Manuela Andrea Hoffmann, Cigdem Soydal, et al.
Turkish Journal of Medical Sciences
|
June 18, 2019
Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment
Kadriye Aydın, Neşe Ersöz Gülçelik, Murat Tuncel, et al.
Radiology and Oncology
|
December 2, 2016
Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma
Kursat Okuyucu, Sukru Ozaydın, Engin Alagoz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 17, 2022
To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment
Murat Tuncel, Alexis Vrachimis, Alfredo Campenni, et al.
Cancers
|
February 25, 2023
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. <i>Cancers</i> 2022, <i>14</i>, 5461
Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
Cancers
|
November 11, 2022
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis
Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
Biomarkers in Medicine
|
March 14, 2025
Relationship between HE4 levels and metabolic parameters in PET of non-small cell lung cancer patients
Yiğit Yilmaz, Mesut Melih Özercan, Burcu Ancin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 31, 2020
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients
Cem Onal, Gokhan Ozyigit, Ozan Cem Guler, et al.
European Urology Oncology
|
February 9, 2022
Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse
Rie von Eyben, Manuela Andrea Hoffmann, Daniel S Kapp, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
European Journal of Nuclear Medicine and Molecular Imaging
|
November 12, 2025
The 2025 ATA guidelines for differentiated thyroid Cancer - Ten years of professional debate and measured progress
Petra Petranović Ovčariček, Frederik Anton Verburg, Bart de Keizer, et al.
Biomedicines
|
September 28, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
Rie von Eyben, Manuela Andrea Hoffmann, Cigdem Soydal, et al.
Turkish Journal of Medical Sciences
|
June 18, 2019
Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment
Kadriye Aydın, Neşe Ersöz Gülçelik, Murat Tuncel, et al.
Radiology and Oncology
|
December 2, 2016
Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma
Kursat Okuyucu, Sukru Ozaydın, Engin Alagoz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 17, 2022
To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment
Murat Tuncel, Alexis Vrachimis, Alfredo Campenni, et al.
Cancers
|
February 25, 2023
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. <i>Cancers</i> 2022, <i>14</i>, 5461
Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
Cancers
|
November 11, 2022
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis
Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
Biomarkers in Medicine
|
March 14, 2025
Relationship between HE4 levels and metabolic parameters in PET of non-small cell lung cancer patients
Yiğit Yilmaz, Mesut Melih Özercan, Burcu Ancin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 31, 2020
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients
Cem Onal, Gokhan Ozyigit, Ozan Cem Guler, et al.
European Urology Oncology
|
February 9, 2022
Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse
Rie von Eyben, Manuela Andrea Hoffmann, Daniel S Kapp, et al.
Page
of 9